Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
CVKD:NASDAQ
Cadrenal Therapeutics Inc
$5.50
-0.54%
(-0.030) 1D
Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVKD...
Open
$5.50
High
$5.86
Low
$5.35
Mkt. cap
13.79M
Avg. vol.
48.23K
Volume
3.00
52-wk high
$17.50
52-wk low
$4.21
EPS
-$6.64
Beta
1.53
Shares outstanding
2.51M
No. of employees
5
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
16 hours ago
Understanding the Setup: (CVKD) and Scalable Risk
About Cadrenal Therapeutics Inc
CEO-
Employees5
Founded2022
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.67M
1.08M
688.46K
666.32K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.25M
2.66M
2.04M
2.40M
Operating expense
3.93M
3.73M
2.73M
3.07M
Total operating expenses
3.93M
3.73M
2.73M
3.07M
Operating income
-3.93M
-3.73M
-2.73M
-3.07M
Other non operating income
-
-
-
-
EBT including unusual items
-3.85M
-3.67M
-2.69M
-3.04M
EBT excluding unusual items
-3.85M
-3.67M
-2.69M
-3.04M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.85M
-3.67M
-2.69M
-3.04M
Net profit margin
-
-
-
-
Earnings per share
-2.09
-1.87
-1.31
-1.41
Interest and investment income
82.60K
67.00K
48.10K
26.12K
Interest expense
-
-
-
-
Net interest expenses
82.60K
67.00K
48.10K
26.12K
Depreciation and amortization charges
5.52K
401.00
401.00
555.00
EBITDA
-3.92M
-3.73M
-2.73M
-3.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more